In D-galactose-induced aging in mice, lycopene in combination with nicotinamide mononucleotide could prevent cognitive impairment and attenuate oxidative damage by acting on the Keap1-Nrf2 signaling pathway [113]. The gene discussed is NFE2L2; the disease is Cognitive impairment.